Yale University

Pharmacokinetic interactions between buprenorphine/naloxone and once-daily lopinavir/ritonavir.

TitlePharmacokinetic interactions between buprenorphine/naloxone and once-daily lopinavir/ritonavir.
Publication TypeJournal Article
Year of Publication2010
AuthorsBruce, Robert Douglas, Frederick L. Altice, David E. Moody, Gene D. Morse, Laurie Andrews, Shen-Nan Lin, Wenfang B. Fang, Qing Ma, and Gerald H. Friedland
JournalJournal of acquired immune deficiency syndromes (1999)
Volume54
Issue5
Pagination511-4
Date Published2010 Aug
ISSN1944-7884
KeywordsAdult, Analgesics, Opioid, Anti-HIV Agents, Buprenorphine, Drug Interactions, Female, HIV Infections, Humans, Lopinavir, Male, Metabolic Clearance Rate, Middle Aged, Naloxone, Pyrimidinones, Ritonavir
AbstractThis study was conducted to examine the pharmacokinetic interactions between buprenorphine/naloxone (BUP/NLX) and lopinavir/ritonavir (LPV/r) in HIV-seronegative subjects chronically maintained on BUP/NLX.
DOI10.1002/hpm.1029
Alternate JournalJ. Acquir. Immune Defic. Syndr.

External Links